A549 NSCLC cells treated with TGF-β1 generate cells with mesenchymal phenotype (A549M), which express CSC markers such as SOX2, NANOG, EpCAM (epithelial cell adhesion molecule), and are resistant to erlotinib. The gene discussed is EPCAM; the disease is non-small cell lung carcinoma.